Biolidics Receives SGX Approval to List 946 Million Share

MT Newswires09-30

Biolidics (SGX:8YY) has received the listing and quotation notice from the Singapore Exchange to list and quote 946 million new shares, according to a Monday filing on the Singapore Exchange.

This includes 452 million shares to shareholders Yuan Zhijun and Wu Kunwei, 407 million subscription shares to Zhu Hua, 76 million sign on shares to Chen Lu, and 11 million to Icon Law LLC.

The company must place out these shares within seven market days.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment